134 related articles for article (PubMed ID: 8408738)
1. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects.
Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
J Clin Pharmacol; 1993 Aug; 33(8):756-61. PubMed ID: 8408738
[TBL] [Abstract][Full Text] [Related]
2. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects.
Shiga T; Fujimura A; Tateishi T; Ohashi K; Ebihara A
Eur J Clin Pharmacol; 1993; 44(5):489-92. PubMed ID: 8359189
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hyperlipidemia on pharmacodynamics of propranolol and atenolol].
Telatyńska-Smieszek B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol Arch Med Wewn; 2004 Jan; 111(1):45-51. PubMed ID: 15088420
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative study.
Wójcicki J; Wojciechowski G; Wójcicki M; Kostyrka R; Sterna R; Gawronska-Szklarz B; Pawlik A; Drozdzik M; Kozlowski K
Eur J Clin Pharmacol; 2000 Apr; 56(1):75-9. PubMed ID: 10853882
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjects.
Wójcicki J; Jaroszynska M; Droździk M; Pawlik A; Gawrońska-Szklarz B; Sterna R
Biopharm Drug Dispos; 2003 Jul; 24(5):211-8. PubMed ID: 12784321
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics of propranolol and atenolol in primary hyperlipidemia.
Telatyńska B; Wójcicki J; Droździk M; Gawrońska-Szklarz B; Sulzyc-Bielicka V; Sterna R
Pol J Pharmacol; 2003; 55(1):81-9. PubMed ID: 12856830
[TBL] [Abstract][Full Text] [Related]
7. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
Telatyńska-Smieszek B
Ann Acad Med Stetin; 2002; 48():367-80. PubMed ID: 14601489
[TBL] [Abstract][Full Text] [Related]
9. Exercise and the pharmacokinetics of propranolol, verapamil and atenolol.
van Baak MA; Mooij JM; Schiffers PM
Eur J Clin Pharmacol; 1992; 43(5):547-50. PubMed ID: 1483493
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of dilevalol (i.v.). Influence of hepatic and renal functions on the disposition of dilevalol and atenolol in hypertensive subjects.
Kotegawa T; Fujimura A; Ebihara A
J Clin Pharmacol; 1990 May; 30(5):404-8. PubMed ID: 2347954
[TBL] [Abstract][Full Text] [Related]
11. Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.
Fujimura A; Kumagai Y; Sugimoto K; Nakashima H; Kajiyama H; Ebihara A; Ohashi K
Eur J Clin Pharmacol; 1990; 38(2):133-7. PubMed ID: 2338109
[TBL] [Abstract][Full Text] [Related]
12. Comparative bioavailability of two atenolol tablet formulations in healthy male volunteers after a single dose administration.
Martins ML; Pierossi MA; Moraes LA; Ribeiro W; Abbib Júnior E; Mendes GB; Poli A; De Nucci G; Muscará MN
Int J Clin Pharmacol Ther; 1997 Aug; 35(8):324-8. PubMed ID: 9266287
[TBL] [Abstract][Full Text] [Related]
13. Effect of diltiazem on the pharmacokinetics of propranolol, metoprolol and atenolol.
Tateishi T; Nakashima H; Shitou T; Kumagai Y; Ohashi K; Hosoda S; Ebihara A
Eur J Clin Pharmacol; 1989; 36(1):67-70. PubMed ID: 2917591
[TBL] [Abstract][Full Text] [Related]
14. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
Carmona MJ; Pereira VA; Malbouisson LM; Auler JO; Santos SR
Braz J Med Biol Res; 2009 Jun; 42(6):574-81. PubMed ID: 19448909
[TBL] [Abstract][Full Text] [Related]
15. The distribution of propranolol, pindolol and atenolol between human erythrocytes and plasma.
Taylor EA; Turner P
Br J Clin Pharmacol; 1981 Oct; 12(4):543-8. PubMed ID: 7295488
[TBL] [Abstract][Full Text] [Related]
16. The interactions between nisoldipine and two beta-adrenoceptor antagonists--atenolol and propranolol.
Elliott HL; Meredith PA; McNally C; Reid JL
Br J Clin Pharmacol; 1991 Sep; 32(3):379-85. PubMed ID: 1777376
[TBL] [Abstract][Full Text] [Related]
17. Prolonged beta blockade due to tertatolol: a comparative study with propranolol and atenolol.
Desche P; Cournot A; Guery O; Prost JF; Duchier J
Fundam Clin Pharmacol; 1987; 1(4):253-6. PubMed ID: 3501763
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the side effects of atenolol and propranolol in the treatment of patients with hypertension.
Fodor JG; Chockalingam A; Drover A; Fifield F; Pauls CJ
J Clin Pharmacol; 1987 Nov; 27(11):892-901. PubMed ID: 2892865
[TBL] [Abstract][Full Text] [Related]
19. Steady state relative bioavailability and pharmacokinetics of oral propranolol in black and white North Americans.
Sharoky M; Perkal M; Turner R; Lesko LJ
Biopharm Drug Dispos; 1988; 9(5):447-56. PubMed ID: 3224162
[TBL] [Abstract][Full Text] [Related]
20. Oral bioavailability of atenolol.
Vergin H; Nitsche V
J Int Med Res; 1989; 17(5):417-25. PubMed ID: 2806714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
